all patients | FL[−] Caucasian | FL[+] Caucasian | P1 | FL[−] African | FL[+] African | P2 | ||
n | 568 | 141 | 374 | ~ | 34 | 19 | ~ | |
age | years | 70 (12) | 73 (13) | 70 (11) | 0.0158 | 62 (16) | 59 (12) | NS |
diabetes duration | years | 19 (10) | 20 (10) | 19 (9) | NS | 20 (12) | 14 (6) | 0.0190 |
family history T2DM | % | 48 | 47 | 48 | NS | 45 | 47 | NS |
family history EOCHD | % | 13 | 14 | 13 | NS | 4 | 6 | NS |
male - female | % | 63 - 37 | 62 - 38 | 64 - 36 | NS | 53 - 47 | 53 - 47 | NS |
education* | % | 50 - 50 | 49 - 51 | 51 - 49 | NS | 52 - 48 | 35 - 65 | NS |
smoking** | % | 50 - 50 | 56 - 44 | 44 - 56 | 0.0176 | 81 - 19 | 79 - 21 | NS |
ethanol | U∙week−1 | 8 (11) | 7 (10) | 8 (12) | NS | 6 (10) | 7 (10) | NS |
sedentarity | % | 62 | 53 | 68 | 0.0020 | 59 | 26 | NS |
physical activity | min∙week−1 | 58 (111) | 74 (125) | 47 (99) | 0.0221 | 59 (104) | 141 (181) | NS |
hypertension | % | 89 | 86 | 91 | NS | 85 | 74 | NS |
systolic blood pressure | mm Hg | 138 (19) | 140 (20) | 138 (19) | NS | 135 (15) | 132 (16) | NS |
anti-dyslipidemic drug(s) | % | 79 | 75 | 84 | 0.0206 | 53 | 44 | NS |
statin - fibrate - ezetimibe | % | 70 - 21 - 13 | 68 - 17 - 17 | 74 - 26 - 11 | NS | 50 - 3 - 15 | 44 - 0 - 6 | NS |
eGFR | mL∙min−1. 1.73 m2 | 74 (28) | 70 (26) | 74 (27) | NS | 85 (37) | 98 (25) | NS |